Biosynex Wins $5.7M BARDA-Supported Award for Biothreat Test
Subsidiary Chembio received a BARDA-supported award to advance its DPP Biothreat Panel over 20 months, aiming for FDA clearance of a rapid multiplex test for three pathogens and integration with the DPP Micro Reader.